Company intelligence / Profile preview

Mary's Brands

Denver, Colorado, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Mary’s Brands develops and commercializes cannabinoid-based wellness products, notably award‑winning transdermal patches, gels, and topicals for humans and pets; products are marketed through adult‑use/medical cannabis channels (THC line) and hemp‑derived CBD channels and are supported by internal QC and third‑party testing rather than formal drug‑development style clinical trials.[1][4][5][6]

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Small moleculeTopical formulationTransdermal deliveryTinctureCapsulePet supplement
Industry: Food & Nutrition

Partnerships

Research and educational collaborations with unspecified institutions and medical professionals focused on cannabinoid therapy[2]Strategic capital partnership between parent BR Brands and Rose Capital, supporting Mary’s Brands’ growth[4][13]

Beyond the preview

Go deeper on Mary's Brands.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mary's Brands.

Explore the full profile